Invesco
WVE icon

Invesco’s Wave Life Sciences WVE Stock Holding History

Invesco’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Buy
199,740
+19,808
+11% +$258K ﹤0.01% 2701
2025
Q4 		$3.06M Buy
179,932
+38,806
+27% +$394K ﹤0.01% 2445
2025
Q3 		$1.03M Buy
141,126
+26,167
+23% +$212K ﹤0.01% 2915
2025
Q2 		$747K Buy
114,959
+36,079
+46% +$238K ﹤0.01% 2982
2025
Q1 		$637K Buy
78,880
+38,870
+97% +$425K ﹤0.01% 3055
2024
Q4 		$495K Buy
40,010
+4,351
+12% +$58.1K ﹤0.01% 3238
2024
Q3 		$292K Buy
35,659
+517
+1% +$3.09K ﹤0.01% 3429
2024
Q2 		$175K Sell
35,142
-8,851
-20% -$50.5K ﹤0.01% 3657
2024
Q1 		$271K Buy
43,993
+6,216
+16% +$31.1K ﹤0.01% 3557
2023
Q4 		$191K Buy
37,777
+5,705
+18% +$30.5K ﹤0.01% 3578
2023
Q3 		$184K Sell
32,072
-718
-2% -$3.28K ﹤0.01% 3617
2023
Q2 		$119K Buy
+32,790
New +$132K ﹤0.01% 3695
2022
Q2 		– Sell
-16,735
Closed -$34K – 4156
2022
Q1 		$34K Buy
16,735
+1,695
+11% +$4.15K ﹤0.01% 3957
2021
Q4 		$47K Sell
15,040
-511
-3% -$2.12K ﹤0.01% 3985
2021
Q3 		$76K Buy
15,551
+3,004
+24% +$18.2K ﹤0.01% 3972
2021
Q2 		$84K Buy
+12,547
New +$82K ﹤0.01% 3916
2019
Q2 		– Sell
-20,914
Closed -$813K – 3782
2019
Q1 		$813K Sell
20,914
-163,130
-89% -$6.62M ﹤0.01% 3122
2018
Q4 		$7.74M Buy
184,044
+7,546
+4% +$336K ﹤0.01% 1672
2018
Q3 		$8.82M Buy
+176,498
New +$7.96M ﹤0.01% 1789

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco's WVE Position: Q1 2026 in Review

Invesco increased its Wave Life Sciences (WVE) stake by 11% in Q1 2026, buying an estimated $258K and bringing the position to 199,740 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2701.

Invesco first reported a position in WVE in Q3 2018 and has held it in 19 quarters since. The position peaked at $8.82M in Q3 2018. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Invesco held 199,740 shares of Wave Life Sciences worth $1.45M as of Q1 2026.
  • Invesco bought 19,808 Wave Life Sciences shares in Q1 2026, an estimated $258K.
  • Wave Life Sciences made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2701 holding.
  • Invesco first reported a position in Wave Life Sciences in Q3 2018 and has held it in 19 quarters since.
  • Invesco's Wave Life Sciences position peaked at $8.82M in Q3 2018.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.